Bio-Rad Laboratories Inc. (BIO)
NYSE
Real-time Data
01:30 PM
Day's Range
373.4752 wk Range
236.73Overview - BIO - Bio-Rad Laboratories Inc.
Key Statistics
Valuation
Enterprise Value
9.81B
P/E (Trailing)
‪46.49‬
P/E (Forward)
‪38.06‬
PEG Ratio
‪2.44‬
Price / Sales (TTM)
‪3.94‬
Price / Book
‪1.42‬
EV / EBITDA
‪22.26‬
Profitability
Gross Margin
‪53.11%‬
Profit Margin
‪8.58%‬
Operating Margin
‪11.18%‬
Return on Assets
‪1.66%‬
Return on Equity
‪3.11%‬
Ownership
Shares Outstanding
26.73M
Float
20.88M
Short % of Shares Outstanding
‪0.00%‬
Held by Insiders
‪16.35%‬
Held by Institutions
‪91.24%‬
Price stats
Beta
‪1.04‬
50-Day Avg
‪314.15‬
200-Day Avg
‪297.89‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
5 analysts
Average price target
‪$ 329.00‬Shariah Compliance
Report Date: Feb 20, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - BIO - Bio-Rad Laboratories Inc.
Peers - BIO - Bio-Rad Laboratories Inc.
Peer Comparison
Compared with companies in Medical Devices listed on NYSE.
Profile Summary - BIO - Bio-Rad Laboratories Inc.
About
Bio-Rad Laboratories, Inc. develops, manufactures, and markets specialized products for the clinical diagnostics and life sciences markets. In clinical diagnostics, the company provides test systems and quality control solutions for clinical laboratories. In life sciences, it produces instruments and reagents for…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
